B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the main curative therapy for hematological malignancy such as leukemias, lymphomas, or multiple myelomas and some other hematological disorders. In this therapy, cure of hematological diseases relies on graft-versus-malignancy effect...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Juric, Mateja Kralj, Shevtsov, Maxim, Mozes, Petra, Ogonek, Justyna, Crossland, Rachel E., Dickinson, Anne M., Greinix, Hildegard T., Holler, Ernst, Weissinger, Eva M., Multhoff, Gabriele
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5238459/
https://ncbi.nlm.nih.gov/pubmed/28138325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars